New COVID variant JN.1 now comprises up to 30% of US cases: CDC

By FOX News
| January 03, 2024

Fast-spreading variant is expected to respond to current vaccines and treatments, experts say.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...